HEPATITIS B, CHRONIC

This large Phase 3 study is testing whether an experimental drug called bepirovirsen can help people with chronic hepatitis B achieve a 'functional cure.' This means the virus becomes undetectable and stays that way after stopping all treatment. The trial involves 981 participant…

This study is testing whether new drug combinations can help control chronic hepatitis B infection. Researchers are giving 244 adults with long-term hepatitis B different combinations of experimental drugs to see if they're safe and effective. The main goal is to see if these tre…

This study is testing an investigational drug called AHB-137 in adults with a specific type of chronic hepatitis B. Participants are already taking stable antiviral pills. The goal is to see if adding AHB-137 can further reduce the amount of virus in the blood and potentially imp…

This large Phase 3 trial is testing whether a drug called bepirovirsen can help people with chronic hepatitis B achieve a 'functional cure.' The study involves 857 participants who are already on standard antiviral medication. Researchers want to see if adding bepirovirsen for 24…

This early-stage study is testing a new injectable drug called AHB-137 for people with chronic Hepatitis B. The main goals are to check if the drug is safe and to see if it can reduce the amount of virus in the body. The study includes both healthy volunteers and Hepatitis B pati…

This study is testing whether some adults with chronic hepatitis B can safely stop their long-term antiviral medication. Researchers will follow 140 patients who stop treatment and compare them to 700 similar patients who continue medication. The goal is to see if stopping is saf…